What is Annexon's stock issuance proceeds?

Annexon (ANNX) reported stock issuance proceeds of $33.6M in Q1 2026.

What is the long-term trend for Annexon's stock issuance proceeds?

Over 3 years (2021 to 2025), Annexon's stock issuance proceeds has grown at a 160.6% compound annual growth rate (CAGR), from $1.61M to $28.49M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Annexon ANNX Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Regeneron PharmaceuticalsREGN

$163.1M+169%

Dianthus TherapeuticsDNTH

$120K-7.0%

Cullinan Therapeutics, Inc.CGEM

$0-100%

Nektar TherapeuticsNKTR

$1.07B+506,582%

AnaptysBio, Inc.ANAB

$14.02M+4,735%

Jade Biosciences, Inc. Common StockJBIO

$45K+105%

Other financials

Income statement

See full

Operating income-$46.1M+19.8%

Net income-$44.1M+18.8%

EPS (diluted)-$0.23+37.8%

Balance sheet

See full

Cash & equivalents$175.2M+80.4%

Total debt$25.4M-10.2%

Total equity$204.5M-16.1%

Total assets$262.9M-13.2%

Cash flow

See full

Operating cash flow-$46.8M+6.5%

CapEx--100%

Free cash flow-$46.8M+6.6%

Valuation

See full

Market cap$868.37M+223%

Enterprise value$718.59M+261%

Returns & leverage

See full

Return on equity-87.6%+42.3pp

Debt / equity0.1×0.0×

Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Annexon's stock issuance proceeds?: Annexon (ANNX) reported stock issuance proceeds of $33.6M in Q1 2026.
What is the long-term trend for Annexon's stock issuance proceeds?: Over 3 years (2021 to 2025), Annexon's stock issuance proceeds has grown at a 160.6% compound annual growth rate (CAGR), from $1.61M to $28.49M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.